AHA: Decision on Spironolactone in HF a Toss-Up? (CME/CE)

DALLAS (MedPage Today) -- The TOPCAT trial evaluating spironolactone in patients with heart failure and preserved ejection fraction did not meet its primary endpoint, but there was some evidence of benefit, a researcher reported here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news